Literature DB >> 14197149

HEMOLYTIC ANEMIA SECONDARY TO SALICYLAZOSULFAPYRIDINE THERAPY.

M D GARDNER, J A BARGEN.   

Abstract

Entities:  

Keywords:  ANEMIA, CHEMICAL INDUCED HEMOLYTIC; BLOOD CELL COUNT; COLITIS, ULCERATIVE; DRUG THERAPY; HEMATOCRIT; HEMOGLOBINOMETRY; SALICYLAZOSULFAPYRIDINE; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14197149

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis.

Authors:  R E Pounder; E R Craven; J S Henthorn; J M Bannatyne
Journal:  Gut       Date:  1975-03       Impact factor: 23.059

2.  Salicylazosulfapyridine in inflammatory bowel disease.

Authors:  K M Das; I Sternlieb
Journal:  Am J Dig Dis       Date:  1975-10

3.  Agranulocytosis associated with sulphasalazine therapy.

Authors:  P Cochrane; P Atkins; S Ehsanullah
Journal:  Postgrad Med J       Date:  1973-09       Impact factor: 2.401

Review 4.  Clinical pharmacokinetics of sulphasalazine.

Authors:  K M Das; R Dubin
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.